These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17672444)

  • 1. C1'-cycloalkyl side chain pharmacophore in tetrahydrocannabinols.
    Papahatjis DP; Nahmias VR; Nikas SP; Andreou T; Alapafuja SO; Tsotinis A; Guo J; Fan P; Makriyannis A
    J Med Chem; 2007 Aug; 50(17):4048-60. PubMed ID: 17672444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'.
    Papahatjis DP; Nikas SP; Kourouli T; Chari R; Xu W; Pertwee RG; Makriyannis A
    J Med Chem; 2003 Jul; 46(15):3221-9. PubMed ID: 12852753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unsaturated side chain beta-11-hydroxyhexahydrocannabinol analogs.
    Busch-Petersen J; Hill WA; Fan P; Khanolkar A; Xie XQ; Tius MA; Makriyannis A
    J Med Chem; 1996 Sep; 39(19):3790-6. PubMed ID: 8809166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.
    Papahatjis DP; Kourouli T; Abadji V; Goutopoulos A; Makriyannis A
    J Med Chem; 1998 Mar; 41(7):1195-200. PubMed ID: 9544219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids.
    Papahatjis DP; Nahmias VR; Andreou T; Fan P; Makriyannis A
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1616-20. PubMed ID: 16387492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the substituent effects on a novel series of C1'-dimethyl-aryl Delta8-tetrahydrocannabinol analogs.
    Krishnamurthy M; Gurley S; Moore BM
    Bioorg Med Chem; 2008 Jul; 16(13):6489-500. PubMed ID: 18524604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2.
    Durdagi S; Kapou A; Kourouli T; Andreou T; Nikas SP; Nahmias VR; Papahatjis DP; Papadopoulos MG; Mavromoustakos T
    J Med Chem; 2007 Jun; 50(12):2875-85. PubMed ID: 17521177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabilactones: a novel class of CB2 selective agonists with peripheral analgesic activity.
    Khanolkar AD; Lu D; Ibrahim M; Duclos RI; Thakur GA; Malan TP; Porreca F; Veerappan V; Tian X; George C; Parrish DA; Papahatjis DP; Makriyannis A
    J Med Chem; 2007 Dec; 50(26):6493-500. PubMed ID: 18038967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 1',1'-chain substituted hexahydrocannabinols: 9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid receptor 1 (CB1) agonist.
    Nikas SP; Alapafuja SO; Papanastasiou I; Paronis CA; Shukla VG; Papahatjis DP; Bowman AL; Halikhedkar A; Han X; Makriyannis A
    J Med Chem; 2010 Oct; 53(19):6996-7010. PubMed ID: 20925434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activation.
    Berglund BA; Fleming PR; Rice KC; Shim JY; Welsh WJ; Howlett AC
    Drug Des Discov; 2000; 16(4):281-94. PubMed ID: 10807034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantioselective synthesis of 1-methoxy- and 1-deoxy-2'-methyl-delta8-tetrahydrocannabinols: new selective ligands for the CB2 receptor.
    Huffman JW; Bushell SM; Joshi SN; Wiley JL; Martin BR
    Bioorg Med Chem; 2006 Jan; 14(1):247-62. PubMed ID: 16165365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical/nonclassical hybrid cannabinoids: southern aliphatic chain-functionalized C-6beta methyl, ethyl, and propyl analogues.
    Drake DJ; Jensen RS; Busch-Petersen J; Kawakami JK; Concepcion Fernandez-Garcia M; Fan P; Makriyannis A; Tius MA
    J Med Chem; 1998 Sep; 41(19):3596-608. PubMed ID: 9733485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of halogen substitution in classical cannabinoids: a CB1 pharmacophore model.
    Nikas SP; Grzybowska J; Papahatjis DP; Charalambous A; Banijamali AR; Chari R; Fan P; Kourouli T; Lin S; Nitowski AJ; Marciniak G; Guo Y; Li X; Wang CL; Makriyannis A
    AAPS J; 2004 Oct; 6(4):e30. PubMed ID: 15760095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles.
    Huffman JW; Szklennik PV; Almond A; Bushell K; Selley DE; He H; Cassidy MP; Wiley JL; Martin BR
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4110-3. PubMed ID: 16005223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.
    Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J
    Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
    Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
    Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adamantyl cannabinoids: a novel class of cannabinergic ligands.
    Lu D; Meng Z; Thakur GA; Fan P; Steed J; Tartal CL; Hurst DP; Reggio PH; Deschamps JR; Parrish DA; George C; Järbe TU; Lamb RJ; Makriyannis A
    J Med Chem; 2005 Jul; 48(14):4576-85. PubMed ID: 15999995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.
    Martin BR; Jefferson R; Winckler R; Wiley JL; Huffman JW; Crocker PJ; Saha B; Razdan RK
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1065-79. PubMed ID: 10454479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors.
    Hanus LO; Tchilibon S; Ponde DE; Breuer A; Fride E; Mechoulam R
    Org Biomol Chem; 2005 Mar; 3(6):1116-23. PubMed ID: 15750656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1'-Azacycloalkyl Hexahydrocannabinols.
    Ho TC; Shimada N; Tius MA; Nikas SP; Zhang W; Makriyannis A
    J Org Chem; 2017 Aug; 82(15):7839-7849. PubMed ID: 28677397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.